Fortrea (FTRE) Stock: Buy, Sell, or Hold?
FTRE - Fortrea Holdings Inc. Common Stock
$23.51
-0.41 (-1.71%)
▼
5d:
+4.54%
30d:
+17.43%
90d:
+22.45%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Oct 29, 2026
5d
Get Alerted When FTRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: FTRE shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: FTRE shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$34.58
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$21.47
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: FTRE is currently trading at $23.51, which is considered extended relative to its 30-day fair value range of $19.34 to $22.15. From a valuation perspective, the stock is trading at a premium (Forward PE: 21.1) compared to its historical average (15.7). At these levels, the market is pricing in 10.3% annual earnings growth.
Technical Outlook: Technically, FTRE is in a strong uptrend. Immediate support is located at $20.25, while resistance sits at $24.84.
Market Sentiment: FTRE scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FTRE is in a strong uptrend. Immediate support is located at $20.25, while resistance sits at $24.84.
Market Sentiment: FTRE scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$19.34 -
$22.15
Company Quality Score
31/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
20.0%
All Signals
- BEARISH: Price extended above range (+6.1% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($21.71)
- BULLISH: Expecting earnings turnaround to 10.3% growth with -4.5% revenue growth
- WARNING: Composite score 31/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$19.34 -
$22.15
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$20.25
Resistance Level
$24.84
Current Trend
Strong Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
21.15
Wall Street Target
$21.71
(-9.2%)
Revenue Growth (YoY)
-4.5%
Earnings Growth (YoY)
-57.4%
Profit Margin
-3.2%
Valuation Premium vs History
+10.3% premium
PE vs Historical
21.2 vs 15.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+10.3%
(market-implied from PE analysis)
1-Year Target
$26.38
(+10%)
2-Year Target
$29.10
(+22%)
3-Year Target
$32.10
(+34%)
3-Yr Target (if PE normalizes)
(PE: 21→16)
PE COMPRESSION
$23.83
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.1, Growth: 33.7%)
$57.19
(+139%)
Base:
(SPY PE: 19.9, Growth: 33.7%)
$53.71
(+125%)
Bear:
(PE: 15.7, Growth: 33.7%)
$42.46
(+78%)
Share & Embed Analysis
Last updated: October 23, 2026 3:40 PM ET
Data refreshes hourly during market hours. Next update: 4:40 PM
Data refreshes hourly during market hours. Next update: 4:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FTRE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$92 | 73 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
23 analysts |
$108 | 58 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$130 | 69 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$283 | 43 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
20 analysts |
$17 | 47 HOLD |
